ORIGINAL RESEARCH article

Front. Mol. Biosci.

Sec. Molecular Diagnostics and Therapeutics

Volume 12 - 2025 | doi: 10.3389/fmolb.2025.1580880

This article is part of the Research TopicExploring Molecular Recognition: Integrating Experimental and Computational ApproachesView all 4 articles

Identification of biomarkers and immune microenvironment associated with heart failure through bioinformatics and machine learning

Provisionally accepted
Jingyun  JinJingyun Jin1Shuyan  QinShuyan Qin2Fu  QiangFu Qiang3Changzhi  YuChangzhi Yu2Hongjin  WuHongjin Wu4*
  • 1Shanghai University of Traditional Chinese Medicine, Shanghai, China
  • 2Nanyang Second General Hospital, Nanyang, China
  • 3Department of Traditional Chinese Medicine, Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, Shenzhen, China
  • 4Beijing Haidian Hospital, Peking University, Haidian, Beijing, China

The final, formatted version of the article will be published soon.

Heart failure(HF) is the end stage of various cardiovascular diseases. Identifying new biomarkers is essential for early diagnosis, prognosis, and treatment. This study applied bioinformatics to identify potential HF biomarkers and explore the role of the immune microenvironment.Gene expression data were obtained from the Gene Expression Omnibus(GEO) database. Differential expression analysis and Weighted Gene Co-expression Network Analysis(WGCNA) were used to identify key genes. Gene Ontology(GO), Kyoto Encyclopedia of Genes and Genomes(KEGG), and Gene Set Enrichment Analysis were performed. Feature genes were further determined using two machine learning algorithms, Random Forest (RF) and Least Absolute Shrinkage and Selection Operator(LASSO), with diagnostic accuracy assessed via Receiver Operating Characteristic(ROC) curves and nomograms to screen hub genes, and external datasets further were used for validation. Quantitative reverse transcription polymerase chain reaction (RT-qPCR) was used to validate the expression levels of hub genes in clinical samples.Single Sample Gene Set Enrichment Analysis and CIBERSORT algorithm were applied to evaluate immune cell infiltration in HF and its relationship with hub genes.Differential analysis identified 165 differentially expressed genes (DEGs), and WGCNA revealed the "blue" module showing a significant correlation with HF.Integration of the DEGs and the "blue" module genes identified 28 common genes.KEGG pathway enrichment analysis suggested that these genes may be involved in the cytoskeleton in muscle cells pathway. Lasso and RF algorithms confirmed 7 key genes as potential biomarkers for HF, and further analysis using the ROC curve identified 4 hub genes with good diagnostic value, namely High mobility group N 2 (HMGN2), Myosin Heavy Chain 6 (MYH6), High temperature requirement A1 (HTRA1), and Microfibrillar-associated protein 4 (MFAP4), which were validated in an external dataset and by RT-qPCR. Immune infiltration analysis revealed significant infiltration of immune cells in HF. T cells, NK cells, monocytes, and M2 macrophages play important roles in the development of HF, and the hub genes were closely associated with multiple immune cell types.This study identifies HMGN2, HTRA1, MFAP4, and MYH6 as novel diagnostic biomarkers and potential therapeutic targets for HF. These genes are closely related to the immune microenvironment, providing new insights into the early diagnosis, treatment, and mechanistic exploration of HF.

Keywords: Heart Failure, biomarkers, bioinformatics, weighted gene co-expression network analysis, machine learning, Immune infiltration

Received: 21 Feb 2025; Accepted: 21 Apr 2025.

Copyright: © 2025 Jin, Qin, Qiang, Yu and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Hongjin Wu, Beijing Haidian Hospital, Peking University, Haidian, 100871, Beijing, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.